Annual Net Income
-$526.24 M
-$137.29 M-35.30%
31 December 2023
Summary:
Cytokinetics Incorporated annual net profit is currently -$526.24 million, with the most recent change of -$137.29 million (-35.30%) on 31 December 2023. During the last 3 years, it has fallen by -$398.95 million (-313.42%). CYTK annual net income is now -2244.08% below its all-time high of $24.54 million, reached on 31 December 2009.CYTK Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Net Income
-$160.54 M
-$17.23 M-12.02%
30 September 2024
Summary:
Cytokinetics Incorporated quarterly net profit is currently -$160.54 million, with the most recent change of -$17.23 million (-12.02%) on 30 September 2024. Over the past year, it has dropped by -$31.12 million (-24.05%). CYTK quarterly net income is now -386.90% below its all-time high of $55.96 million, reached on 30 June 2009.CYTK Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Net Income
-$576.40 M
-$31.12 M-5.71%
30 September 2024
Summary:
Cytokinetics Incorporated TTM net profit is currently -$576.40 million, with the most recent change of -$31.12 million (-5.71%) on 30 September 2024. Over the past year, it has dropped by -$49.67 million (-9.43%). CYTK TTM net income is now -2298.66% below its all-time high of $26.22 million, reached on 30 September 2009.CYTK TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CYTK Net Income Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -35.3% | -24.1% | -9.4% |
| 3 y3 years | -313.4% | -111.0% | -152.1% |
| 5 y5 years | -395.1% | -442.9% | -390.5% |
CYTK Net Income High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -313.4% | at low | -710.0% | at low | -167.7% | at low |
| 5 y | 5 years | -395.1% | at low | -4956.5% | at low | -405.6% | at low |
| alltime | all time | -2244.1% | at low | -386.9% | at low | -2298.7% | at low |
Cytokinetics Incorporated Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$160.54 M(+12.0%) | -$576.40 M(+5.7%) |
| June 2024 | - | -$143.32 M(+5.7%) | -$545.28 M(+2.8%) |
| Mar 2024 | - | -$135.64 M(-0.9%) | -$530.60 M(+0.8%) |
| Dec 2023 | -$526.24 M(+35.3%) | -$136.90 M(+5.8%) | -$526.24 M(-0.1%) |
| Sept 2023 | - | -$129.42 M(+0.6%) | -$526.73 M(-2.4%) |
| June 2023 | - | -$128.64 M(-2.0%) | -$539.62 M(+25.3%) |
| Mar 2023 | - | -$131.29 M(-4.4%) | -$430.80 M(+10.8%) |
| Dec 2022 | -$388.95 M(+80.6%) | -$137.38 M(-3.5%) | -$388.95 M(+37.9%) |
| Sept 2022 | - | -$142.31 M(+618.0%) | -$282.14 M(+30.7%) |
| June 2022 | - | -$19.82 M(-77.8%) | -$215.92 M(-16.2%) |
| Mar 2022 | - | -$89.44 M(+192.6%) | -$257.65 M(+19.7%) |
| Dec 2021 | -$215.31 M(+69.2%) | -$30.57 M(-59.8%) | -$215.31 M(-5.8%) |
| Sept 2021 | - | -$76.09 M(+23.6%) | -$228.67 M(+46.8%) |
| June 2021 | - | -$61.55 M(+30.7%) | -$155.76 M(+15.4%) |
| Mar 2021 | - | -$47.10 M(+7.2%) | -$134.99 M(+6.0%) |
| Dec 2020 | -$127.29 M(+4.6%) | -$43.93 M(+1283.6%) | -$127.29 M(+11.7%) |
| Sept 2020 | - | -$3.17 M(-92.2%) | -$114.00 M(-18.8%) |
| June 2020 | - | -$40.78 M(+3.5%) | -$140.40 M(+6.6%) |
| Mar 2020 | - | -$39.41 M(+28.6%) | -$131.73 M(+8.2%) |
| Dec 2019 | -$121.69 M(+14.5%) | -$30.64 M(+3.6%) | -$121.69 M(+3.6%) |
| Sept 2019 | - | -$29.57 M(-7.9%) | -$117.52 M(+6.9%) |
| June 2019 | - | -$32.11 M(+9.4%) | -$109.96 M(+4.4%) |
| Mar 2019 | - | -$29.37 M(+10.9%) | -$105.37 M(-0.9%) |
| Dec 2018 | -$106.29 M(-16.8%) | -$26.47 M(+20.2%) | -$106.29 M(-11.7%) |
| Sept 2018 | - | -$22.02 M(-20.0%) | -$120.31 M(-7.9%) |
| June 2018 | - | -$27.52 M(-9.1%) | -$130.65 M(-1.2%) |
| Mar 2018 | - | -$30.28 M(-25.2%) | -$132.20 M(+3.5%) |
| Dec 2017 | -$127.79 M(-876.7%) | -$40.48 M(+25.1%) | -$127.79 M(+59.4%) |
| Sept 2017 | - | -$32.36 M(+11.3%) | -$80.15 M(+455.5%) |
| June 2017 | - | -$29.08 M(+12.4%) | -$14.43 M(-574.5%) |
| Mar 2017 | - | -$25.87 M(-461.4%) | $3.04 M(-81.5%) |
| Dec 2016 | $16.45 M(-143.9%) | $7.16 M(-78.5%) | $16.45 M(>+9900.0%) |
| Sept 2016 | - | $33.36 M(-387.3%) | $67.00 K(-100.2%) |
| June 2016 | - | -$11.61 M(-6.8%) | -$42.14 M(+2.6%) |
| Mar 2016 | - | -$12.46 M(+35.0%) | -$41.08 M(+9.6%) |
| Dec 2015 | -$37.50 M(+156.0%) | -$9.23 M(+4.3%) | -$37.50 M(+89.1%) |
| Sept 2015 | - | -$8.85 M(-16.1%) | -$19.83 M(+17.0%) |
| June 2015 | - | -$10.55 M(+18.9%) | -$16.95 M(+14.7%) |
| Mar 2015 | - | -$8.87 M(-205.1%) | -$14.77 M(+0.9%) |
| Dec 2014 | -$14.65 M(-56.6%) | $8.44 M(-241.4%) | -$14.65 M(-11.5%) |
| Sept 2014 | - | -$5.97 M(-28.7%) | -$16.56 M(-28.6%) |
| June 2014 | - | -$8.37 M(-4.2%) | -$23.18 M(-22.3%) |
| Mar 2014 | - | -$8.74 M(-233.9%) | -$29.84 M(-11.5%) |
| Dec 2013 | -$33.72 M | $6.53 M(-151.9%) | -$33.72 M(-34.8%) |
| Sept 2013 | - | -$12.59 M(-16.3%) | -$51.70 M(+5.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2013 | - | -$15.04 M(+19.2%) | -$49.16 M(+14.2%) |
| Mar 2013 | - | -$12.62 M(+10.2%) | -$43.06 M(+6.7%) |
| Dec 2012 | -$40.37 M(-15.6%) | -$11.46 M(+14.1%) | -$40.37 M(-1.0%) |
| Sept 2012 | - | -$10.04 M(+12.3%) | -$40.79 M(-1.4%) |
| June 2012 | - | -$8.94 M(-9.9%) | -$41.39 M(-10.2%) |
| Mar 2012 | - | -$9.93 M(-16.4%) | -$46.08 M(-3.7%) |
| Dec 2011 | -$47.86 M(-2.9%) | -$11.88 M(+11.6%) | -$47.86 M(+0.6%) |
| Sept 2011 | - | -$10.64 M(-22.0%) | -$47.60 M(-3.5%) |
| June 2011 | - | -$13.63 M(+16.4%) | -$49.30 M(+1.0%) |
| Mar 2011 | - | -$11.71 M(+0.9%) | -$48.81 M(-1.0%) |
| Dec 2010 | -$49.29 M(-300.8%) | -$11.61 M(-5.9%) | -$49.29 M(-1.8%) |
| Sept 2010 | - | -$12.34 M(-6.1%) | -$50.20 M(+9.0%) |
| June 2010 | - | -$13.14 M(+7.8%) | -$46.06 M(-299.9%) |
| Mar 2010 | - | -$12.19 M(-2.7%) | $23.04 M(-6.1%) |
| Dec 2009 | $24.54 M(-143.5%) | -$12.53 M(+52.8%) | $24.54 M(-6.4%) |
| Sept 2009 | - | -$8.20 M(-114.7%) | $26.22 M(+44.4%) |
| June 2009 | - | $55.96 M(-623.7%) | $18.16 M(-134.2%) |
| Mar 2009 | - | -$10.69 M(-1.6%) | -$53.16 M(-5.7%) |
| Dec 2008 | -$56.37 M(+15.3%) | -$10.86 M(-33.2%) | -$56.37 M(-4.1%) |
| Sept 2008 | - | -$16.26 M(+5.8%) | -$58.77 M(+9.2%) |
| June 2008 | - | -$15.36 M(+10.6%) | -$53.83 M(+5.4%) |
| Mar 2008 | - | -$13.89 M(+4.9%) | -$51.10 M(+4.5%) |
| Dec 2007 | -$48.89 M(-14.4%) | -$13.25 M(+17.1%) | -$48.89 M(-5.2%) |
| Sept 2007 | - | -$11.32 M(-10.4%) | -$51.59 M(-6.5%) |
| June 2007 | - | -$12.63 M(+8.0%) | -$55.19 M(-2.1%) |
| Mar 2007 | - | -$11.69 M(-26.7%) | -$56.34 M(-1.4%) |
| Dec 2006 | -$57.12 M(+35.2%) | -$15.95 M(+6.9%) | -$57.12 M(+9.3%) |
| Sept 2006 | - | -$14.92 M(+8.2%) | -$52.25 M(+10.2%) |
| June 2006 | - | -$13.79 M(+10.6%) | -$47.43 M(+7.3%) |
| Mar 2006 | - | -$12.46 M(+12.5%) | -$44.19 M(+4.6%) |
| Dec 2005 | -$42.25 M(+13.6%) | -$11.08 M(+9.7%) | -$42.25 M(-1.7%) |
| Sept 2005 | - | -$10.10 M(-4.2%) | -$42.99 M(-0.3%) |
| June 2005 | - | -$10.54 M(+0.1%) | -$43.11 M(+3.1%) |
| Mar 2005 | - | -$10.53 M(-10.9%) | -$41.80 M(+12.4%) |
| Dec 2004 | -$37.20 M(+13.8%) | -$11.82 M(+15.7%) | -$37.20 M(+10.9%) |
| Sept 2004 | - | -$10.22 M(+10.7%) | -$33.55 M(+6.5%) |
| June 2004 | - | -$9.23 M(+55.6%) | -$31.50 M(+5.0%) |
| Mar 2004 | - | -$5.93 M(-27.4%) | -$30.01 M(-3.8%) |
| Dec 2003 | -$32.69 M(+41.6%) | -$8.17 M(0.0%) | -$31.21 M(+35.5%) |
| Sept 2003 | - | -$8.17 M(+5.6%) | -$23.04 M(+55.0%) |
| June 2003 | - | -$7.74 M(+8.5%) | -$14.87 M(+108.5%) |
| Mar 2003 | - | -$7.13 M | -$7.13 M |
| Dec 2002 | -$23.08 M(+45.4%) | - | - |
| Dec 2001 | -$15.87 M(+21.4%) | - | - |
| Dec 2000 | -$13.08 M | - | - |
FAQ
- What is Cytokinetics Incorporated annual net profit?
- What is the all time high annual net income for Cytokinetics Incorporated?
- What is Cytokinetics Incorporated annual net income year-on-year change?
- What is Cytokinetics Incorporated quarterly net profit?
- What is the all time high quarterly net income for Cytokinetics Incorporated?
- What is Cytokinetics Incorporated quarterly net income year-on-year change?
- What is Cytokinetics Incorporated TTM net profit?
- What is the all time high TTM net income for Cytokinetics Incorporated?
- What is Cytokinetics Incorporated TTM net income year-on-year change?
What is Cytokinetics Incorporated annual net profit?
The current annual net income of CYTK is -$526.24 M
What is the all time high annual net income for Cytokinetics Incorporated?
Cytokinetics Incorporated all-time high annual net profit is $24.54 M
What is Cytokinetics Incorporated annual net income year-on-year change?
Over the past year, CYTK annual net profit has changed by -$137.29 M (-35.30%)
What is Cytokinetics Incorporated quarterly net profit?
The current quarterly net income of CYTK is -$160.54 M
What is the all time high quarterly net income for Cytokinetics Incorporated?
Cytokinetics Incorporated all-time high quarterly net profit is $55.96 M
What is Cytokinetics Incorporated quarterly net income year-on-year change?
Over the past year, CYTK quarterly net profit has changed by -$31.12 M (-24.05%)
What is Cytokinetics Incorporated TTM net profit?
The current TTM net income of CYTK is -$576.40 M
What is the all time high TTM net income for Cytokinetics Incorporated?
Cytokinetics Incorporated all-time high TTM net profit is $26.22 M
What is Cytokinetics Incorporated TTM net income year-on-year change?
Over the past year, CYTK TTM net profit has changed by -$49.67 M (-9.43%)